Theunissen EL
Department of Neuropsychology & Psychopharmacology, Faculty of Psychology & Neuroscience, Maastricht University, Maastricht, The Netherlands.
ArticleLSD
A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers.
ArticleDMT
Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT.
ArticlePsychedelics
Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.
ArticleLSD
Inter-individual variability in neural response to low doses of LSD.
ArticleDMT
A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression.
ArticlePsilocybin
Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.
PreprintPsilocybin
Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition
ArticleLSD
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants.
ArticleLSD
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study.
ArticleLSD
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers.
ArticleLSD
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.
ArticleAyahuasca